206 research outputs found
Effective Field Theory for the perturbations of a slowly rotating black hole
We develop the effective theory for perturbations around black holes with scalar hair, in two directions. First, we show that the scalar-Gauss-Bonnet theory, often used as an example exhibiting scalar black hole hair, can be deformed by galileon operators leading to order unity changes to its predictions. The effective theory for perturbations thus provides an efficient framework for describing and constraining broad classes of scalar-tensor theories, of which the addition of galileon operators is an example. Second, we extend the effective theory to perturbations around an axisymmetric, slowly rotating black hole, at linear order in the black hole spin. We also discuss the inclusion of parity-breaking operators in the effective theory.We develop the effective theory for perturbations around black holes with scalar hair, in two directions. First, we show that the scalar-Gauss-Bonnet theory, often used as an example exhibiting scalar black hole hair, can be deformed by galileon operators leading to order unity changes to its predictions. The effective theory for perturbations thus provides an efficient framework for describing and constraining broad classes of scalar-tensor theories, of which the addition of galileon operators is an example. Second, we extend the effective theory to perturbations around an axisymmetric, slowly rotating black hole, at linear order in the black hole spin. We also discuss the inclusion of parity-breaking operators in the effective theory
Pengaruh Terapi Pijat Refleksi Kaki Terhadap Ankle Brachial Index (Abi) Pada Pasien Diabetes Melitus Tipe 2
Diabetes melitus adalah suatu penyakit kronis yang merupakan masalah kesehatan dunia yang serius. World Health Organization (WHO) memperkirakan di Asia Tenggara ada 30 juta penderita DM pada tahun 2000 dan diprediksi akan meningkat sampai 80 juta pada tahun 2025. Jumlah ini merupakan yang tertinggi di dunia (Wild, et al., 2009). Diabetes melitus merupakan sekelompok kelainan heterogen yang ditandai oleh kenaikan kadar glukosa dalam darah atau hiperglikemia (Smeltzer & Bare, 2010). Saat ini angka pasien diabetes melitus bertambah banyak, WHO memprediksi bahwa pada tahun 2000 jumlah pengidap diabetes di atas umur 20 tahun berjumlah 150 juta orang di dunia dan dalam kurun waktu 25 tahun kemudian, pada tahun 2025 jumlah tersebut akan membengkak menjadi 300 juta orang. Diabetes melitus di Indonesia diprediksi mengalami kenaikan jumlah pasien dari 8,4 juta pada tahun 2000 menjadi sekitar 21,3 juta pada tahun 2030Penelitian ini bertujuan untuk mengetahui pengaruh terapi pijat refleksi kaki terhadap ankle brachial index (ABI) pada pasien diabetesmelitus tipe 2.Penelitian ini menggunakan rancangan eksperimen semu dengan desain pre test- post test design. Respondennya 64 pasien diabetes melitus tipe 2 yang dirawat jalan di RS PKU Muhammadiyah Gombong pada bulan Mei 2014, terdiri dari 32 responden kontrol dan 32 responden intervensi. Teknik pengumpulan datanya menggunakan pengukuran dan dokumentasi dengan bantuan instrumen doppler Ultrasound 8MHz dan Sphygnomano meter, lembar dokumentasi karakteristik responden, lembar pengukuran ABI, panduan pemeriksaan ABI, dan panduan pijat refleksi kaki. Teknik analisis datanya menggunakan Paired t Test dan t Test, yang sebelumnya telah dilakukan uji prasyarat analisis meliputi uji normalitas, homogenitas, dan kesetaraan.Setelah dilakukan analisis diperoleh hasil terapi pijat refleksi kaki berpengaruh signifikan dalam meningkatkan ankle brachial index (ABI) pada pasien diabetes melitus tipe 2 di RS PKU Muhammadiyah Gombong, terbukti dari: (a) terjadi peningkatan ABI yang signifikan pada kelompok intervensi; (b) tidak terjadi peningkatan ABI yang signifikan pada kelompok kontrol; (c) sesudah penelitian ABI kelompok intervensi secara signifikan lebih tinggi dibandingkan ABI kelompok kontrol; (d) peningkatan ABI kelompok intervensi secara signifikan lebih tinggi dibandingkan peningkatan ABI kelompok kontrol
Study the effect of beam energy spread and detector resolution on the search for Higgs boson decays to invisible particles at a future e + e - circular collider
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells
Breast cancer in kurdish women of northern Iraq: incidence, clinical stage, and case control analysis of parity and family risk
<p>Abstract</p> <p>Background</p> <p>Breast cancer in the Middle-East occurs in relatively young women and frequently presents as advanced disease. A protective effect of multiparity is not apparent, and high familial risk is reported in some countries. This study investigates breast cancer rates and clinical stage related to age in the Kurdish region of Iraq and evaluates risk associated with parity and family history. Findings are compared with nearby countries and the West.</p> <p>Methods</p> <p>Sulaimaniyah Directorate of Health records identified 539 women diagnosed with breast cancer during 2006-2008. Clinical survey forms were completed on 296 patients and on 254 age-matched controls. Age specific incidence rates were calculated from Directorate of Health population estimates.</p> <p>Results</p> <p>Average patient age was 47.4 ± 11 years and 59.5% were pre-menopausal. Diagnosis was at clinical stage 1 for 4.1%, stage 2 for 43.5%, stage 3 for 26.0%, and stage 4 for 8.1% of patients. For 18.2%, stage was unknown. Annual breast cancer incidence rates per 100,000 women peaked at 168.9 at age 55 to 59 and declined to 57.3 at 60 and above. Patients had an average of 5.0 ± 3.3 children compared to 5.4 ± 3.5 for controls, <it>P </it>= 0.16. A first degree family member had breast cancer among 11.1% of patients and 2.1% of controls (<it>P </it>< 0.001) with > 50% of these patients and controls being ≥50 years old. No statistically significant relationship was found between tumor stage and age, <it>P </it>= 0.59.</p> <p>Conclusions</p> <p>In Kurdish Iraq, breast cancer is predominantly a disease of pre-menopausal women having multiple pregnancies. For younger patients, breast cancer incidence was similar to the West and possibly higher than many Middle-Eastern countries, but unlike the West, the estimated rates declined markedly in the elderly. The familial breast cancer risk for both older and younger women was within the general population risk of Western countries. Clinical stages were advanced and indicated delays in diagnosis that were unrelated to patient age.</p
Multicenter comparative multimodality surveillance of women at genetic-familial risk for breast cancer (HIBCRIT study): interim results.
PURPOSE: To prospectively compare clinical breast examination (CBE), mammography, ultrasonography (US), and contrast material-enhanced magnetic resonance (MR) imaging for screening women at genetic-familial high risk for breast cancer and report interim results, with pathologic findings as standard. MATERIALS AND METHODS: Institutional review board of each center approved the research; informed written consent was obtained. CBE, mammography, US, and MR imaging were performed for yearly screening of BRCA1 or BRCA2 mutation carriers, first-degree relatives of BRCA1 or BRCA2 mutation carriers, or women enrolled because of a strong family history of breast or ovarian cancer (three or more events in first- or second-degree relatives in either maternal or paternal line; these included breast cancer in women younger than 60 years, ovarian cancer at any age, and male breast cancer at any age). RESULTS: Two hundred seventy-eight women (mean age, 46 years +/- 12 [standard deviation]) were enrolled. Breast cancer was found in 11 of 278 women at first round and seven of 99 at second round (14 invasive, four intraductal; eight were <or=10 mm in diameter). Detection rate per year was 4.8% (18 of 377) overall; 4.3% (11 of 258) in BRCA1 or BRCA2 mutation carriers and first-degree relatives of BRCA1 or BRCA2 mutation carriers versus 5.9% (seven of 119) in women enrolled because of strong family history; and 5.3% (nine of 169) in women with previous personal breast and/or ovarian cancer versus 4.3% (nine of 208) in those without. In six (33%) of 18 patients, cancer was detected only with MR imaging. Sensitivity was as follows: CBE, 50% (95% confidence interval [CI]: 29%, 71%); mammography, 59% (95% CI: 36%, 78%); US, 65% (95% CI: 41%, 83%); and MR imaging, 94% (95% CI: 82%, 99%). Positive predictive value was as follows: CBE, 82% (95% CI: 52%, 95%); mammography, 77% (95% CI: 50%, 92%); US, 65% (95% CI: 41%, 83%); and MR imaging, 63% (95% CI: 43%, 79%). CONCLUSION: Addition of MR imaging to the screening regimen for high-risk women may enable detection of otherwise unsuspected breast cancers. (c) RSNA, 2007
Activation of phosphatidylcholinespecific phospholipase C in breast and ovarian cancer: Impact on mrs-detected choline metabolic profile and perspectives for targeted therapy
Elucidation of molecular mechanisms underlying the aberrant phosphatidylcholine cycle in cancer cells plays in favor of the use of metabolic imaging in oncology and opens the way for designing new targeted therapies. The anomalous choline metabolic profile detected in cancer by magnetic resonance spectroscopy and spectroscopic imaging provides molecular signatures of tumor progression and response to therapy. The increased level of intracellular phosphocholine (PCho) typically detected in cancer cells is mainly attributed to upregulation of choline kinase, responsible for choline phosphorylation in the biosynthetic Kennedy pathway, but can also be partly produced by activation of phosphatidylcholine-specific phospholipase C (PC-PLC). This hydrolytic enzyme, known for implications in bacterial infection and in plant survival to hostile environmental conditions, is reported to be activated in mitogen- and oncogene-induced phosphatidylcholine cycles in mammalian cells, with effects on cell signaling, cell cycle regulation, and cell proliferation. Recent investigations showed that PC-PLC activation could account for 20-50% of the intracellular PCho production in ovarian and breast cancer cells of different subtypes. Enzyme activation was associated with PC-PLC protein overexpression and subcellular redistribution in these cancer cells compared with non-tumoral counterparts. Moreover, PC-PLC coimmunoprecipitated with the human epidermal growth factor receptor-2 (HER2) and EGFR in HER2-overexpressing breast and ovarian cancer cells, while pharmacological PC-PLC inhibition resulted into long-lasting HER2 downregulation, retarded receptor re-expression on plasma membrane and antiproliferative effects. This body of evidence points to PC-PLC as a potential target for newly designed therapies, whose effects can be preclinically and clinically monitored by metabolic imaging methods
Influence of washing and quenching in profiling the metabolome of adherent mammalian cells: A case study with the metastatic breast cancer cell line MDA-MB-231
Metabolome characterisation is a powerful tool in oncology. To obtain a valid description of the intracellular
metabolome, two of the preparatory steps are crucial, namely washing and quenching. Washing
must effectively remove the extracellular media components and quenching should stop the metabolic
activities within the cell, without altering the membrane integrity of the cell. Therefore, it is important to
evaluate the efficiency of the washing and quenching solvents. In this study, we employed two previously
optimised protocols for simultaneous quenching and extraction, and investigated the effects of a number
of washing steps/solvents and quenching solvent additives, on metabolite leakage from the adherent
metastatic breast cancer cell line MDA-MB-231. We explored five washing protocols and five quenching
protocols (including a control for each), and assessed for effectiveness by detecting ATP in the medium
and cell morphology changes through scanning electron microscopy (SEM) analyses. Furthermore, we
studied the overall recovery of eleven different metabolite classes using the GC-MS technique and compared
the results with those obtained from the ATP assay and SEM analysis. Our data demonstrate that a
single washing step with PBS and quenching with 60% methanol supplemented with 70 mM HEPES
(−50 °C) results in minimum leakage of intracellular metabolites. Little or no interference of PBS (used in
washing) and methanol/HEPES (used in quenching) on the subsequent GC-MS analysis step was noted.
Together, these findings provide for the first time a systematic study into the washing and quenching
steps of the metabolomics workflow for studying adherent mammalian cells, which we believe will
improve reliability in the application of metabolomics technology to study adherent mammalian cell
metabolism
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study
Ovarian carcinomas represent a major form of gynaecological malignancies, whose treatment consists mainly of surgery and chemotherapy. Besides the difficulty of prognosis, therapy of ovarian carcinomas has reached scarce improvement, as a consequence of lack of efficacy and development of drug-resistance. The need of different biochemical and functional parameters has grown, in order to obtain a larger view on processes of biological and clinical significance. In this paper we report novel metabolic features detected in a series of different human ovary carcinoma lines, by 1H NMR spectroscopy of intact cells and their extracts. Most importantly, a new ovarian adenocarcinoma line CABA I, showed strong signals in the spectral region between 3.5 and 4.0 p.p.m., assigned for the first time to the polyol sorbitol (39±11 nmol/106 cells). 13C NMR analyses of these cells incubated with [1-13C]-D-glucose demonstrated labelled-sorbitol formation. The other ovarian carcinoma cell lines (OVCAR-3, IGROV 1, SK-OV-3 and OVCA432), showed, in the same spectral region, intense resonances from other metabolites: glutathione (up to 30 nmol/106 cells) and myo-inositol (up to 50 nmol/106 cells). Biochemical and biological functions are suggested for these compounds in human ovarian carcinoma cells, especially in relation to their possible role in cell detoxification mechanisms during tumour progression
1H nuclear magnetic resonance spectroscopy characterisation of metabolic phenotypes in the medulloblastoma of the SMO transgenic mice
BACKGROUND: Human medulloblastomas exhibit diverse molecular pathology. Aberrant hedgehog signalling is found in 20-30% of human medulloblastomas with largely unknown metabolic consequences. METHODS: Transgenic mice over-expressing smoothened (SMO) receptor in granule cell precursors with high incidence of exophytic medulloblastomas were sequentially followed up by magnetic resonance imaging (MRI) and characterised for metabolite phenotypes by ¹H MR spectroscopy (MRS) in vivo and ex vivo using high-resolution magic angle spinning (HR-MAS) ¹H MRS. RESULTS: Medulloblastomas in the SMO mice presented as T₂ hyperintense tumours in MRI. These tumours showed low concentrations of N-acetyl aspartate and high concentrations of choline-containing metabolites (CCMs), glycine, and taurine relative to the cerebellar parenchyma in the wild-type (WT) C57BL/6 mice. In contrast, ¹H MRS metabolite concentrations in normal appearing cerebellum of the SMO mice were not different from those in the WT mice. Macromolecule and lipid ¹H MRS signals in SMO medulloblastomas were not different from those detected in the cerebellum of WT mice. The HR-MAS analysis of SMO medulloblastomas confirmed the in vivo ¹H MRS metabolite profiles, and additionally revealed that phosphocholine was strongly elevated in medulloblastomas accounting for the high in vivo CCM. CONCLUSIONS: These metabolite profiles closely mirror those reported from human medulloblastomas confirming that SMO mice provide a realistic model for investigating metabolic aspects of this disease. Taurine, glycine, and CCM are potential metabolite biomarkers for the SMO medulloblastomas. The MRS data from the medulloblastomas with defined molecular pathology is discussed in the light of metabolite profiles reported from human tumours
- …